Global Bio Similars & Subsequent Entry Biologic Market Growth (Status and Outlook) 2025-2031
According to this study, the global Bio Similars & Subsequent Entry Biologic market size will reach US$ million by 2031.
Bio Similars, also known as Subsequent Entry Biologics (SEBs), are biological products that are highly similar to an already approved biological reference product. They are designed to have comparable quality, safety, and efficacy to the reference product, and are approved based on demonstrating similarity in terms of structure, function, pharmacokinetics, pharmacodynamics, immunogenicity, and clinical outcomes. Bio Similars are different from generic drugs, which are identical copies of small-molecule drugs that can be easily synthesized.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Bio Similars & Subsequent Entry Biologic Industry Forecast” looks at past sales and reviews total world Bio Similars & Subsequent Entry Biologic sales in 2024, providing a comprehensive analysis by region and market sector of projected Bio Similars & Subsequent Entry Biologic sales for 2025 through 2031. With Bio Similars & Subsequent Entry Biologic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bio Similars & Subsequent Entry Biologic industry.
This Insight Report provides a comprehensive analysis of the global Bio Similars & Subsequent Entry Biologic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bio Similars & Subsequent Entry Biologic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bio Similars & Subsequent Entry Biologic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bio Similars & Subsequent Entry Biologic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bio Similars & Subsequent Entry Biologic.
This report presents a comprehensive overview, market shares, and growth opportunities of Bio Similars & Subsequent Entry Biologic market by product type, application, key players and key regions and countries.
Segmentation by Type:
Bio Similars, also known as Subsequent Entry Biologics (SEBs), are biological products that are highly similar to an already approved biological reference product. They are designed to have comparable quality, safety, and efficacy to the reference product, and are approved based on demonstrating similarity in terms of structure, function, pharmacokinetics, pharmacodynamics, immunogenicity, and clinical outcomes. Bio Similars are different from generic drugs, which are identical copies of small-molecule drugs that can be easily synthesized.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Bio Similars & Subsequent Entry Biologic Industry Forecast” looks at past sales and reviews total world Bio Similars & Subsequent Entry Biologic sales in 2024, providing a comprehensive analysis by region and market sector of projected Bio Similars & Subsequent Entry Biologic sales for 2025 through 2031. With Bio Similars & Subsequent Entry Biologic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bio Similars & Subsequent Entry Biologic industry.
This Insight Report provides a comprehensive analysis of the global Bio Similars & Subsequent Entry Biologic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bio Similars & Subsequent Entry Biologic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bio Similars & Subsequent Entry Biologic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bio Similars & Subsequent Entry Biologic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bio Similars & Subsequent Entry Biologic.
This report presents a comprehensive overview, market shares, and growth opportunities of Bio Similars & Subsequent Entry Biologic market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Monoclonal Antibodies
- Interferon
- Erythropoietin
- Insulin
- Vaccines
- Others
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sun Pharma
- Synthon Pharmaceuticals
- Teva Pharmaceutical Industries
- LG Life Sciences
- Celltrion Biocon
- Hospira
- Merck
- Biogen idec
- Genentech (Roche)
- Pfizer
- Celltrion
- Biocon
- Amgen
- Samsung Biologics
- Mylan
- Dr. Reddy's Laboratories
- Stada Arzneimittel AG
- AbbVie
- Sanofi-Aventis
- Johnson & Johnson
- Novo Nordisk
- Eli Lilly
- Novartis
- 3sbio
- Biotech
- Gelgen
- Innovent
- Dong Bao
- Ganlee
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bio Similars & Subsequent Entry Biologic Market Size (2020-2031)
2.1.2 Bio Similars & Subsequent Entry Biologic Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Bio Similars & Subsequent Entry Biologic by Country/Region (2020, 2024 & 2031)
2.2 Bio Similars & Subsequent Entry Biologic Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Interferon
2.2.3 Erythropoietin
2.2.4 Insulin
2.2.5 Vaccines
2.2.6 Others
2.3 Bio Similars & Subsequent Entry Biologic Market Size by Type
2.3.1 Bio Similars & Subsequent Entry Biologic Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type (2020-2025)
2.4 Bio Similars & Subsequent Entry Biologic Segment by Application
2.4.1 Tumor
2.4.2 Diabetes
2.4.3 Cardiovascular
2.4.4 Hemophilia
2.4.5 Others
2.5 Bio Similars & Subsequent Entry Biologic Market Size by Application
2.5.1 Bio Similars & Subsequent Entry Biologic Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application (2020-2025)
3 BIO SIMILARS & SUBSEQUENT ENTRY BIOLOGIC MARKET SIZE BY PLAYER
3.1 Bio Similars & Subsequent Entry Biologic Market Size Market Share by Player
3.1.1 Global Bio Similars & Subsequent Entry Biologic Revenue by Player (2020-2025)
3.1.2 Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Player (2020-2025)
3.2 Global Bio Similars & Subsequent Entry Biologic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIO SIMILARS & SUBSEQUENT ENTRY BIOLOGIC BY REGION
4.1 Bio Similars & Subsequent Entry Biologic Market Size by Region (2020-2025)
4.2 Global Bio Similars & Subsequent Entry Biologic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bio Similars & Subsequent Entry Biologic Market Size Growth (2020-2025)
4.4 APAC Bio Similars & Subsequent Entry Biologic Market Size Growth (2020-2025)
4.5 Europe Bio Similars & Subsequent Entry Biologic Market Size Growth (2020-2025)
4.6 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025)
5.2 Americas Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025)
5.3 Americas Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio Similars & Subsequent Entry Biologic Market Size by Region (2020-2025)
6.2 APAC Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025)
6.3 APAC Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025)
7.2 Europe Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025)
7.3 Europe Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bio Similars & Subsequent Entry Biologic by Region (2020-2025)
8.2 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025)
8.3 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIO SIMILARS & SUBSEQUENT ENTRY BIOLOGIC MARKET FORECAST
10.1 Global Bio Similars & Subsequent Entry Biologic Forecast by Region (2026-2031)
10.1.1 Global Bio Similars & Subsequent Entry Biologic Forecast by Region (2026-2031)
10.1.2 Americas Bio Similars & Subsequent Entry Biologic Forecast
10.1.3 APAC Bio Similars & Subsequent Entry Biologic Forecast
10.1.4 Europe Bio Similars & Subsequent Entry Biologic Forecast
10.1.5 Middle East & Africa Bio Similars & Subsequent Entry Biologic Forecast
10.2 Americas Bio Similars & Subsequent Entry Biologic Forecast by Country (2026-2031)
10.2.1 United States Market Bio Similars & Subsequent Entry Biologic Forecast
10.2.2 Canada Market Bio Similars & Subsequent Entry Biologic Forecast
10.2.3 Mexico Market Bio Similars & Subsequent Entry Biologic Forecast
10.2.4 Brazil Market Bio Similars & Subsequent Entry Biologic Forecast
10.3 APAC Bio Similars & Subsequent Entry Biologic Forecast by Region (2026-2031)
10.3.1 China Bio Similars & Subsequent Entry Biologic Market Forecast
10.3.2 Japan Market Bio Similars & Subsequent Entry Biologic Forecast
10.3.3 Korea Market Bio Similars & Subsequent Entry Biologic Forecast
10.3.4 Southeast Asia Market Bio Similars & Subsequent Entry Biologic Forecast
10.3.5 India Market Bio Similars & Subsequent Entry Biologic Forecast
10.3.6 Australia Market Bio Similars & Subsequent Entry Biologic Forecast
10.4 Europe Bio Similars & Subsequent Entry Biologic Forecast by Country (2026-2031)
10.4.1 Germany Market Bio Similars & Subsequent Entry Biologic Forecast
10.4.2 France Market Bio Similars & Subsequent Entry Biologic Forecast
10.4.3 UK Market Bio Similars & Subsequent Entry Biologic Forecast
10.4.4 Italy Market Bio Similars & Subsequent Entry Biologic Forecast
10.4.5 Russia Market Bio Similars & Subsequent Entry Biologic Forecast
10.5 Middle East & Africa Bio Similars & Subsequent Entry Biologic Forecast by Region (2026-2031)
10.5.1 Egypt Market Bio Similars & Subsequent Entry Biologic Forecast
10.5.2 South Africa Market Bio Similars & Subsequent Entry Biologic Forecast
10.5.3 Israel Market Bio Similars & Subsequent Entry Biologic Forecast
10.5.4 Turkey Market Bio Similars & Subsequent Entry Biologic Forecast
10.6 Global Bio Similars & Subsequent Entry Biologic Forecast by Type (2026-2031)
10.7 Global Bio Similars & Subsequent Entry Biologic Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Bio Similars & Subsequent Entry Biologic Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sun Pharma
11.1.1 Sun Pharma Company Information
11.1.2 Sun Pharma Bio Similars & Subsequent Entry Biologic Product Offered
11.1.3 Sun Pharma Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Sun Pharma Main Business Overview
11.1.5 Sun Pharma Latest Developments
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Information
11.2.2 Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Product Offered
11.2.3 Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Synthon Pharmaceuticals Main Business Overview
11.2.5 Synthon Pharmaceuticals Latest Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Information
11.3.2 Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Product Offered
11.3.3 Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Teva Pharmaceutical Industries Main Business Overview
11.3.5 Teva Pharmaceutical Industries Latest Developments
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Information
11.4.2 LG Life Sciences Bio Similars & Subsequent Entry Biologic Product Offered
11.4.3 LG Life Sciences Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 LG Life Sciences Main Business Overview
11.4.5 LG Life Sciences Latest Developments
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Information
11.5.2 Celltrion Biocon Bio Similars & Subsequent Entry Biologic Product Offered
11.5.3 Celltrion Biocon Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Celltrion Biocon Main Business Overview
11.5.5 Celltrion Biocon Latest Developments
11.6 Hospira
11.6.1 Hospira Company Information
11.6.2 Hospira Bio Similars & Subsequent Entry Biologic Product Offered
11.6.3 Hospira Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Hospira Main Business Overview
11.6.5 Hospira Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Bio Similars & Subsequent Entry Biologic Product Offered
11.7.3 Merck Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Biogen idec
11.8.1 Biogen idec Company Information
11.8.2 Biogen idec Bio Similars & Subsequent Entry Biologic Product Offered
11.8.3 Biogen idec Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Biogen idec Main Business Overview
11.8.5 Biogen idec Latest Developments
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Information
11.9.2 Genentech (Roche) Bio Similars & Subsequent Entry Biologic Product Offered
11.9.3 Genentech (Roche) Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Genentech (Roche) Main Business Overview
11.9.5 Genentech (Roche) Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Bio Similars & Subsequent Entry Biologic Product Offered
11.10.3 Pfizer Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Celltrion
11.11.1 Celltrion Company Information
11.11.2 Celltrion Bio Similars & Subsequent Entry Biologic Product Offered
11.11.3 Celltrion Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Celltrion Main Business Overview
11.11.5 Celltrion Latest Developments
11.12 Biocon
11.12.1 Biocon Company Information
11.12.2 Biocon Bio Similars & Subsequent Entry Biologic Product Offered
11.12.3 Biocon Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Biocon Main Business Overview
11.12.5 Biocon Latest Developments
11.13 Amgen
11.13.1 Amgen Company Information
11.13.2 Amgen Bio Similars & Subsequent Entry Biologic Product Offered
11.13.3 Amgen Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Amgen Main Business Overview
11.13.5 Amgen Latest Developments
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Information
11.14.2 Samsung Biologics Bio Similars & Subsequent Entry Biologic Product Offered
11.14.3 Samsung Biologics Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Samsung Biologics Main Business Overview
11.14.5 Samsung Biologics Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Bio Similars & Subsequent Entry Biologic Product Offered
11.15.3 Mylan Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Dr. Reddy's Laboratories
11.16.1 Dr. Reddy's Laboratories Company Information
11.16.2 Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Product Offered
11.16.3 Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Dr. Reddy's Laboratories Main Business Overview
11.16.5 Dr. Reddy's Laboratories Latest Developments
11.17 Stada Arzneimittel AG
11.17.1 Stada Arzneimittel AG Company Information
11.17.2 Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Product Offered
11.17.3 Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Stada Arzneimittel AG Main Business Overview
11.17.5 Stada Arzneimittel AG Latest Developments
11.18 AbbVie
11.18.1 AbbVie Company Information
11.18.2 AbbVie Bio Similars & Subsequent Entry Biologic Product Offered
11.18.3 AbbVie Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 AbbVie Main Business Overview
11.18.5 AbbVie Latest Developments
11.19 Sanofi-Aventis
11.19.1 Sanofi-Aventis Company Information
11.19.2 Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Product Offered
11.19.3 Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Sanofi-Aventis Main Business Overview
11.19.5 Sanofi-Aventis Latest Developments
11.20 Johnson & Johnson
11.20.1 Johnson & Johnson Company Information
11.20.2 Johnson & Johnson Bio Similars & Subsequent Entry Biologic Product Offered
11.20.3 Johnson & Johnson Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Johnson & Johnson Main Business Overview
11.20.5 Johnson & Johnson Latest Developments
11.21 Novo Nordisk
11.21.1 Novo Nordisk Company Information
11.21.2 Novo Nordisk Bio Similars & Subsequent Entry Biologic Product Offered
11.21.3 Novo Nordisk Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Novo Nordisk Main Business Overview
11.21.5 Novo Nordisk Latest Developments
11.22 Eli Lilly
11.22.1 Eli Lilly Company Information
11.22.2 Eli Lilly Bio Similars & Subsequent Entry Biologic Product Offered
11.22.3 Eli Lilly Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Eli Lilly Main Business Overview
11.22.5 Eli Lilly Latest Developments
11.23 Novartis
11.23.1 Novartis Company Information
11.23.2 Novartis Bio Similars & Subsequent Entry Biologic Product Offered
11.23.3 Novartis Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 Novartis Main Business Overview
11.23.5 Novartis Latest Developments
11.24 3sbio
11.24.1 3sbio Company Information
11.24.2 3sbio Bio Similars & Subsequent Entry Biologic Product Offered
11.24.3 3sbio Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 3sbio Main Business Overview
11.24.5 3sbio Latest Developments
11.25 Biotech
11.25.1 Biotech Company Information
11.25.2 Biotech Bio Similars & Subsequent Entry Biologic Product Offered
11.25.3 Biotech Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 Biotech Main Business Overview
11.25.5 Biotech Latest Developments
11.26 Gelgen
11.26.1 Gelgen Company Information
11.26.2 Gelgen Bio Similars & Subsequent Entry Biologic Product Offered
11.26.3 Gelgen Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 Gelgen Main Business Overview
11.26.5 Gelgen Latest Developments
11.27 Innovent
11.27.1 Innovent Company Information
11.27.2 Innovent Bio Similars & Subsequent Entry Biologic Product Offered
11.27.3 Innovent Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.27.4 Innovent Main Business Overview
11.27.5 Innovent Latest Developments
11.28 Dong Bao
11.28.1 Dong Bao Company Information
11.28.2 Dong Bao Bio Similars & Subsequent Entry Biologic Product Offered
11.28.3 Dong Bao Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.28.4 Dong Bao Main Business Overview
11.28.5 Dong Bao Latest Developments
11.29 Ganlee
11.29.1 Ganlee Company Information
11.29.2 Ganlee Bio Similars & Subsequent Entry Biologic Product Offered
11.29.3 Ganlee Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.29.4 Ganlee Main Business Overview
11.29.5 Ganlee Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bio Similars & Subsequent Entry Biologic Market Size (2020-2031)
2.1.2 Bio Similars & Subsequent Entry Biologic Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Bio Similars & Subsequent Entry Biologic by Country/Region (2020, 2024 & 2031)
2.2 Bio Similars & Subsequent Entry Biologic Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Interferon
2.2.3 Erythropoietin
2.2.4 Insulin
2.2.5 Vaccines
2.2.6 Others
2.3 Bio Similars & Subsequent Entry Biologic Market Size by Type
2.3.1 Bio Similars & Subsequent Entry Biologic Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type (2020-2025)
2.4 Bio Similars & Subsequent Entry Biologic Segment by Application
2.4.1 Tumor
2.4.2 Diabetes
2.4.3 Cardiovascular
2.4.4 Hemophilia
2.4.5 Others
2.5 Bio Similars & Subsequent Entry Biologic Market Size by Application
2.5.1 Bio Similars & Subsequent Entry Biologic Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application (2020-2025)
3 BIO SIMILARS & SUBSEQUENT ENTRY BIOLOGIC MARKET SIZE BY PLAYER
3.1 Bio Similars & Subsequent Entry Biologic Market Size Market Share by Player
3.1.1 Global Bio Similars & Subsequent Entry Biologic Revenue by Player (2020-2025)
3.1.2 Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Player (2020-2025)
3.2 Global Bio Similars & Subsequent Entry Biologic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIO SIMILARS & SUBSEQUENT ENTRY BIOLOGIC BY REGION
4.1 Bio Similars & Subsequent Entry Biologic Market Size by Region (2020-2025)
4.2 Global Bio Similars & Subsequent Entry Biologic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bio Similars & Subsequent Entry Biologic Market Size Growth (2020-2025)
4.4 APAC Bio Similars & Subsequent Entry Biologic Market Size Growth (2020-2025)
4.5 Europe Bio Similars & Subsequent Entry Biologic Market Size Growth (2020-2025)
4.6 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025)
5.2 Americas Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025)
5.3 Americas Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio Similars & Subsequent Entry Biologic Market Size by Region (2020-2025)
6.2 APAC Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025)
6.3 APAC Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025)
7.2 Europe Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025)
7.3 Europe Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bio Similars & Subsequent Entry Biologic by Region (2020-2025)
8.2 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025)
8.3 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIO SIMILARS & SUBSEQUENT ENTRY BIOLOGIC MARKET FORECAST
10.1 Global Bio Similars & Subsequent Entry Biologic Forecast by Region (2026-2031)
10.1.1 Global Bio Similars & Subsequent Entry Biologic Forecast by Region (2026-2031)
10.1.2 Americas Bio Similars & Subsequent Entry Biologic Forecast
10.1.3 APAC Bio Similars & Subsequent Entry Biologic Forecast
10.1.4 Europe Bio Similars & Subsequent Entry Biologic Forecast
10.1.5 Middle East & Africa Bio Similars & Subsequent Entry Biologic Forecast
10.2 Americas Bio Similars & Subsequent Entry Biologic Forecast by Country (2026-2031)
10.2.1 United States Market Bio Similars & Subsequent Entry Biologic Forecast
10.2.2 Canada Market Bio Similars & Subsequent Entry Biologic Forecast
10.2.3 Mexico Market Bio Similars & Subsequent Entry Biologic Forecast
10.2.4 Brazil Market Bio Similars & Subsequent Entry Biologic Forecast
10.3 APAC Bio Similars & Subsequent Entry Biologic Forecast by Region (2026-2031)
10.3.1 China Bio Similars & Subsequent Entry Biologic Market Forecast
10.3.2 Japan Market Bio Similars & Subsequent Entry Biologic Forecast
10.3.3 Korea Market Bio Similars & Subsequent Entry Biologic Forecast
10.3.4 Southeast Asia Market Bio Similars & Subsequent Entry Biologic Forecast
10.3.5 India Market Bio Similars & Subsequent Entry Biologic Forecast
10.3.6 Australia Market Bio Similars & Subsequent Entry Biologic Forecast
10.4 Europe Bio Similars & Subsequent Entry Biologic Forecast by Country (2026-2031)
10.4.1 Germany Market Bio Similars & Subsequent Entry Biologic Forecast
10.4.2 France Market Bio Similars & Subsequent Entry Biologic Forecast
10.4.3 UK Market Bio Similars & Subsequent Entry Biologic Forecast
10.4.4 Italy Market Bio Similars & Subsequent Entry Biologic Forecast
10.4.5 Russia Market Bio Similars & Subsequent Entry Biologic Forecast
10.5 Middle East & Africa Bio Similars & Subsequent Entry Biologic Forecast by Region (2026-2031)
10.5.1 Egypt Market Bio Similars & Subsequent Entry Biologic Forecast
10.5.2 South Africa Market Bio Similars & Subsequent Entry Biologic Forecast
10.5.3 Israel Market Bio Similars & Subsequent Entry Biologic Forecast
10.5.4 Turkey Market Bio Similars & Subsequent Entry Biologic Forecast
10.6 Global Bio Similars & Subsequent Entry Biologic Forecast by Type (2026-2031)
10.7 Global Bio Similars & Subsequent Entry Biologic Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Bio Similars & Subsequent Entry Biologic Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sun Pharma
11.1.1 Sun Pharma Company Information
11.1.2 Sun Pharma Bio Similars & Subsequent Entry Biologic Product Offered
11.1.3 Sun Pharma Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Sun Pharma Main Business Overview
11.1.5 Sun Pharma Latest Developments
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Information
11.2.2 Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Product Offered
11.2.3 Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Synthon Pharmaceuticals Main Business Overview
11.2.5 Synthon Pharmaceuticals Latest Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Information
11.3.2 Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Product Offered
11.3.3 Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Teva Pharmaceutical Industries Main Business Overview
11.3.5 Teva Pharmaceutical Industries Latest Developments
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Information
11.4.2 LG Life Sciences Bio Similars & Subsequent Entry Biologic Product Offered
11.4.3 LG Life Sciences Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 LG Life Sciences Main Business Overview
11.4.5 LG Life Sciences Latest Developments
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Information
11.5.2 Celltrion Biocon Bio Similars & Subsequent Entry Biologic Product Offered
11.5.3 Celltrion Biocon Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Celltrion Biocon Main Business Overview
11.5.5 Celltrion Biocon Latest Developments
11.6 Hospira
11.6.1 Hospira Company Information
11.6.2 Hospira Bio Similars & Subsequent Entry Biologic Product Offered
11.6.3 Hospira Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Hospira Main Business Overview
11.6.5 Hospira Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Bio Similars & Subsequent Entry Biologic Product Offered
11.7.3 Merck Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Biogen idec
11.8.1 Biogen idec Company Information
11.8.2 Biogen idec Bio Similars & Subsequent Entry Biologic Product Offered
11.8.3 Biogen idec Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Biogen idec Main Business Overview
11.8.5 Biogen idec Latest Developments
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Information
11.9.2 Genentech (Roche) Bio Similars & Subsequent Entry Biologic Product Offered
11.9.3 Genentech (Roche) Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Genentech (Roche) Main Business Overview
11.9.5 Genentech (Roche) Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Bio Similars & Subsequent Entry Biologic Product Offered
11.10.3 Pfizer Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Celltrion
11.11.1 Celltrion Company Information
11.11.2 Celltrion Bio Similars & Subsequent Entry Biologic Product Offered
11.11.3 Celltrion Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Celltrion Main Business Overview
11.11.5 Celltrion Latest Developments
11.12 Biocon
11.12.1 Biocon Company Information
11.12.2 Biocon Bio Similars & Subsequent Entry Biologic Product Offered
11.12.3 Biocon Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Biocon Main Business Overview
11.12.5 Biocon Latest Developments
11.13 Amgen
11.13.1 Amgen Company Information
11.13.2 Amgen Bio Similars & Subsequent Entry Biologic Product Offered
11.13.3 Amgen Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Amgen Main Business Overview
11.13.5 Amgen Latest Developments
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Information
11.14.2 Samsung Biologics Bio Similars & Subsequent Entry Biologic Product Offered
11.14.3 Samsung Biologics Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Samsung Biologics Main Business Overview
11.14.5 Samsung Biologics Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Bio Similars & Subsequent Entry Biologic Product Offered
11.15.3 Mylan Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Dr. Reddy's Laboratories
11.16.1 Dr. Reddy's Laboratories Company Information
11.16.2 Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Product Offered
11.16.3 Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Dr. Reddy's Laboratories Main Business Overview
11.16.5 Dr. Reddy's Laboratories Latest Developments
11.17 Stada Arzneimittel AG
11.17.1 Stada Arzneimittel AG Company Information
11.17.2 Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Product Offered
11.17.3 Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Stada Arzneimittel AG Main Business Overview
11.17.5 Stada Arzneimittel AG Latest Developments
11.18 AbbVie
11.18.1 AbbVie Company Information
11.18.2 AbbVie Bio Similars & Subsequent Entry Biologic Product Offered
11.18.3 AbbVie Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 AbbVie Main Business Overview
11.18.5 AbbVie Latest Developments
11.19 Sanofi-Aventis
11.19.1 Sanofi-Aventis Company Information
11.19.2 Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Product Offered
11.19.3 Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Sanofi-Aventis Main Business Overview
11.19.5 Sanofi-Aventis Latest Developments
11.20 Johnson & Johnson
11.20.1 Johnson & Johnson Company Information
11.20.2 Johnson & Johnson Bio Similars & Subsequent Entry Biologic Product Offered
11.20.3 Johnson & Johnson Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Johnson & Johnson Main Business Overview
11.20.5 Johnson & Johnson Latest Developments
11.21 Novo Nordisk
11.21.1 Novo Nordisk Company Information
11.21.2 Novo Nordisk Bio Similars & Subsequent Entry Biologic Product Offered
11.21.3 Novo Nordisk Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Novo Nordisk Main Business Overview
11.21.5 Novo Nordisk Latest Developments
11.22 Eli Lilly
11.22.1 Eli Lilly Company Information
11.22.2 Eli Lilly Bio Similars & Subsequent Entry Biologic Product Offered
11.22.3 Eli Lilly Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Eli Lilly Main Business Overview
11.22.5 Eli Lilly Latest Developments
11.23 Novartis
11.23.1 Novartis Company Information
11.23.2 Novartis Bio Similars & Subsequent Entry Biologic Product Offered
11.23.3 Novartis Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 Novartis Main Business Overview
11.23.5 Novartis Latest Developments
11.24 3sbio
11.24.1 3sbio Company Information
11.24.2 3sbio Bio Similars & Subsequent Entry Biologic Product Offered
11.24.3 3sbio Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 3sbio Main Business Overview
11.24.5 3sbio Latest Developments
11.25 Biotech
11.25.1 Biotech Company Information
11.25.2 Biotech Bio Similars & Subsequent Entry Biologic Product Offered
11.25.3 Biotech Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 Biotech Main Business Overview
11.25.5 Biotech Latest Developments
11.26 Gelgen
11.26.1 Gelgen Company Information
11.26.2 Gelgen Bio Similars & Subsequent Entry Biologic Product Offered
11.26.3 Gelgen Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 Gelgen Main Business Overview
11.26.5 Gelgen Latest Developments
11.27 Innovent
11.27.1 Innovent Company Information
11.27.2 Innovent Bio Similars & Subsequent Entry Biologic Product Offered
11.27.3 Innovent Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.27.4 Innovent Main Business Overview
11.27.5 Innovent Latest Developments
11.28 Dong Bao
11.28.1 Dong Bao Company Information
11.28.2 Dong Bao Bio Similars & Subsequent Entry Biologic Product Offered
11.28.3 Dong Bao Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.28.4 Dong Bao Main Business Overview
11.28.5 Dong Bao Latest Developments
11.29 Ganlee
11.29.1 Ganlee Company Information
11.29.2 Ganlee Bio Similars & Subsequent Entry Biologic Product Offered
11.29.3 Ganlee Bio Similars & Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2025)
11.29.4 Ganlee Main Business Overview
11.29.5 Ganlee Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Bio Similars & Subsequent Entry Biologic Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Bio Similars & Subsequent Entry Biologic Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Interferon
Table 5. Major Players of Erythropoietin
Table 6. Major Players of Insulin
Table 7. Major Players of Vaccines
Table 8. Major Players of Others
Table 9. Bio Similars & Subsequent Entry Biologic Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025) & ($ millions)
Table 11. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type (2020-2025)
Table 12. Bio Similars & Subsequent Entry Biologic Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025) & ($ millions)
Table 14. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application (2020-2025)
Table 15. Global Bio Similars & Subsequent Entry Biologic Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Player (2020-2025)
Table 17. Bio Similars & Subsequent Entry Biologic Key Players Head office and Products Offered
Table 18. Bio Similars & Subsequent Entry Biologic Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Bio Similars & Subsequent Entry Biologic Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Region (2020-2025)
Table 23. Global Bio Similars & Subsequent Entry Biologic Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Bio Similars & Subsequent Entry Biologic Market Size Market Share by Country (2020-2025)
Table 27. Americas Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type (2020-2025)
Table 29. Americas Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application (2020-2025)
Table 31. APAC Bio Similars & Subsequent Entry Biologic Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Bio Similars & Subsequent Entry Biologic Market Size Market Share by Region (2020-2025)
Table 33. APAC Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Bio Similars & Subsequent Entry Biologic Market Size Market Share by Country (2020-2025)
Table 37. Europe Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Bio Similars & Subsequent Entry Biologic
Table 43. Key Market Challenges & Risks of Bio Similars & Subsequent Entry Biologic
Table 44. Key Industry Trends of Bio Similars & Subsequent Entry Biologic
Table 45. Global Bio Similars & Subsequent Entry Biologic Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global Bio Similars & Subsequent Entry Biologic Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global Bio Similars & Subsequent Entry Biologic Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Sun Pharma Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 50. Sun Pharma Bio Similars & Subsequent Entry Biologic Product Offered
Table 51. Sun Pharma Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Sun Pharma Main Business
Table 53. Sun Pharma Latest Developments
Table 54. Synthon Pharmaceuticals Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 55. Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Product Offered
Table 56. Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Synthon Pharmaceuticals Main Business
Table 58. Synthon Pharmaceuticals Latest Developments
Table 59. Teva Pharmaceutical Industries Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 60. Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Product Offered
Table 61. Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Teva Pharmaceutical Industries Main Business
Table 63. Teva Pharmaceutical Industries Latest Developments
Table 64. LG Life Sciences Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 65. LG Life Sciences Bio Similars & Subsequent Entry Biologic Product Offered
Table 66. LG Life Sciences Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. LG Life Sciences Main Business
Table 68. LG Life Sciences Latest Developments
Table 69. Celltrion Biocon Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 70. Celltrion Biocon Bio Similars & Subsequent Entry Biologic Product Offered
Table 71. Celltrion Biocon Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Celltrion Biocon Main Business
Table 73. Celltrion Biocon Latest Developments
Table 74. Hospira Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 75. Hospira Bio Similars & Subsequent Entry Biologic Product Offered
Table 76. Hospira Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Hospira Main Business
Table 78. Hospira Latest Developments
Table 79. Merck Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 80. Merck Bio Similars & Subsequent Entry Biologic Product Offered
Table 81. Merck Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Biogen idec Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 85. Biogen idec Bio Similars & Subsequent Entry Biologic Product Offered
Table 86. Biogen idec Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Biogen idec Main Business
Table 88. Biogen idec Latest Developments
Table 89. Genentech (Roche) Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 90. Genentech (Roche) Bio Similars & Subsequent Entry Biologic Product Offered
Table 91. Genentech (Roche) Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Genentech (Roche) Main Business
Table 93. Genentech (Roche) Latest Developments
Table 94. Pfizer Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 95. Pfizer Bio Similars & Subsequent Entry Biologic Product Offered
Table 96. Pfizer Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Celltrion Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 100. Celltrion Bio Similars & Subsequent Entry Biologic Product Offered
Table 101. Celltrion Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. Celltrion Main Business
Table 103. Celltrion Latest Developments
Table 104. Biocon Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 105. Biocon Bio Similars & Subsequent Entry Biologic Product Offered
Table 106. Biocon Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. Biocon Main Business
Table 108. Biocon Latest Developments
Table 109. Amgen Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 110. Amgen Bio Similars & Subsequent Entry Biologic Product Offered
Table 111. Amgen Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 112. Amgen Main Business
Table 113. Amgen Latest Developments
Table 114. Samsung Biologics Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 115. Samsung Biologics Bio Similars & Subsequent Entry Biologic Product Offered
Table 116. Samsung Biologics Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 117. Samsung Biologics Main Business
Table 118. Samsung Biologics Latest Developments
Table 119. Mylan Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 120. Mylan Bio Similars & Subsequent Entry Biologic Product Offered
Table 121. Mylan Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 122. Mylan Main Business
Table 123. Mylan Latest Developments
Table 124. Dr. Reddy's Laboratories Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 125. Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Product Offered
Table 126. Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 127. Dr. Reddy's Laboratories Main Business
Table 128. Dr. Reddy's Laboratories Latest Developments
Table 129. Stada Arzneimittel AG Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 130. Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Product Offered
Table 131. Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 132. Stada Arzneimittel AG Main Business
Table 133. Stada Arzneimittel AG Latest Developments
Table 134. AbbVie Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 135. AbbVie Bio Similars & Subsequent Entry Biologic Product Offered
Table 136. AbbVie Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 137. AbbVie Main Business
Table 138. AbbVie Latest Developments
Table 139. Sanofi-Aventis Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 140. Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Product Offered
Table 141. Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 142. Sanofi-Aventis Main Business
Table 143. Sanofi-Aventis Latest Developments
Table 144. Johnson & Johnson Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 145. Johnson & Johnson Bio Similars & Subsequent Entry Biologic Product Offered
Table 146. Johnson & Johnson Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 147. Johnson & Johnson Main Business
Table 148. Johnson & Johnson Latest Developments
Table 149. Novo Nordisk Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 150. Novo Nordisk Bio Similars & Subsequent Entry Biologic Product Offered
Table 151. Novo Nordisk Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 152. Novo Nordisk Main Business
Table 153. Novo Nordisk Latest Developments
Table 154. Eli Lilly Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 155. Eli Lilly Bio Similars & Subsequent Entry Biologic Product Offered
Table 156. Eli Lilly Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 157. Eli Lilly Main Business
Table 158. Eli Lilly Latest Developments
Table 159. Novartis Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 160. Novartis Bio Similars & Subsequent Entry Biologic Product Offered
Table 161. Novartis Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 162. Novartis Main Business
Table 163. Novartis Latest Developments
Table 164. 3sbio Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 165. 3sbio Bio Similars & Subsequent Entry Biologic Product Offered
Table 166. 3sbio Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 167. 3sbio Main Business
Table 168. 3sbio Latest Developments
Table 169. Biotech Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 170. Biotech Bio Similars & Subsequent Entry Biologic Product Offered
Table 171. Biotech Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 172. Biotech Main Business
Table 173. Biotech Latest Developments
Table 174. Gelgen Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 175. Gelgen Bio Similars & Subsequent Entry Biologic Product Offered
Table 176. Gelgen Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 177. Gelgen Main Business
Table 178. Gelgen Latest Developments
Table 179. Innovent Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 180. Innovent Bio Similars & Subsequent Entry Biologic Product Offered
Table 181. Innovent Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 182. Innovent Main Business
Table 183. Innovent Latest Developments
Table 184. Dong Bao Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 185. Dong Bao Bio Similars & Subsequent Entry Biologic Product Offered
Table 186. Dong Bao Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 187. Dong Bao Main Business
Table 188. Dong Bao Latest Developments
Table 189. Ganlee Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 190. Ganlee Bio Similars & Subsequent Entry Biologic Product Offered
Table 191. Ganlee Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 192. Ganlee Main Business
Table 193. Ganlee Latest Developments
Table 1. Bio Similars & Subsequent Entry Biologic Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Bio Similars & Subsequent Entry Biologic Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Interferon
Table 5. Major Players of Erythropoietin
Table 6. Major Players of Insulin
Table 7. Major Players of Vaccines
Table 8. Major Players of Others
Table 9. Bio Similars & Subsequent Entry Biologic Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025) & ($ millions)
Table 11. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type (2020-2025)
Table 12. Bio Similars & Subsequent Entry Biologic Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025) & ($ millions)
Table 14. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application (2020-2025)
Table 15. Global Bio Similars & Subsequent Entry Biologic Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Player (2020-2025)
Table 17. Bio Similars & Subsequent Entry Biologic Key Players Head office and Products Offered
Table 18. Bio Similars & Subsequent Entry Biologic Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Bio Similars & Subsequent Entry Biologic Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Region (2020-2025)
Table 23. Global Bio Similars & Subsequent Entry Biologic Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Bio Similars & Subsequent Entry Biologic Market Size Market Share by Country (2020-2025)
Table 27. Americas Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type (2020-2025)
Table 29. Americas Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application (2020-2025)
Table 31. APAC Bio Similars & Subsequent Entry Biologic Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Bio Similars & Subsequent Entry Biologic Market Size Market Share by Region (2020-2025)
Table 33. APAC Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Bio Similars & Subsequent Entry Biologic Market Size Market Share by Country (2020-2025)
Table 37. Europe Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Bio Similars & Subsequent Entry Biologic
Table 43. Key Market Challenges & Risks of Bio Similars & Subsequent Entry Biologic
Table 44. Key Industry Trends of Bio Similars & Subsequent Entry Biologic
Table 45. Global Bio Similars & Subsequent Entry Biologic Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global Bio Similars & Subsequent Entry Biologic Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global Bio Similars & Subsequent Entry Biologic Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Sun Pharma Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 50. Sun Pharma Bio Similars & Subsequent Entry Biologic Product Offered
Table 51. Sun Pharma Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Sun Pharma Main Business
Table 53. Sun Pharma Latest Developments
Table 54. Synthon Pharmaceuticals Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 55. Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Product Offered
Table 56. Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Synthon Pharmaceuticals Main Business
Table 58. Synthon Pharmaceuticals Latest Developments
Table 59. Teva Pharmaceutical Industries Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 60. Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Product Offered
Table 61. Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Teva Pharmaceutical Industries Main Business
Table 63. Teva Pharmaceutical Industries Latest Developments
Table 64. LG Life Sciences Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 65. LG Life Sciences Bio Similars & Subsequent Entry Biologic Product Offered
Table 66. LG Life Sciences Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. LG Life Sciences Main Business
Table 68. LG Life Sciences Latest Developments
Table 69. Celltrion Biocon Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 70. Celltrion Biocon Bio Similars & Subsequent Entry Biologic Product Offered
Table 71. Celltrion Biocon Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Celltrion Biocon Main Business
Table 73. Celltrion Biocon Latest Developments
Table 74. Hospira Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 75. Hospira Bio Similars & Subsequent Entry Biologic Product Offered
Table 76. Hospira Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Hospira Main Business
Table 78. Hospira Latest Developments
Table 79. Merck Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 80. Merck Bio Similars & Subsequent Entry Biologic Product Offered
Table 81. Merck Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Biogen idec Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 85. Biogen idec Bio Similars & Subsequent Entry Biologic Product Offered
Table 86. Biogen idec Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Biogen idec Main Business
Table 88. Biogen idec Latest Developments
Table 89. Genentech (Roche) Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 90. Genentech (Roche) Bio Similars & Subsequent Entry Biologic Product Offered
Table 91. Genentech (Roche) Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Genentech (Roche) Main Business
Table 93. Genentech (Roche) Latest Developments
Table 94. Pfizer Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 95. Pfizer Bio Similars & Subsequent Entry Biologic Product Offered
Table 96. Pfizer Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Celltrion Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 100. Celltrion Bio Similars & Subsequent Entry Biologic Product Offered
Table 101. Celltrion Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. Celltrion Main Business
Table 103. Celltrion Latest Developments
Table 104. Biocon Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 105. Biocon Bio Similars & Subsequent Entry Biologic Product Offered
Table 106. Biocon Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. Biocon Main Business
Table 108. Biocon Latest Developments
Table 109. Amgen Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 110. Amgen Bio Similars & Subsequent Entry Biologic Product Offered
Table 111. Amgen Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 112. Amgen Main Business
Table 113. Amgen Latest Developments
Table 114. Samsung Biologics Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 115. Samsung Biologics Bio Similars & Subsequent Entry Biologic Product Offered
Table 116. Samsung Biologics Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 117. Samsung Biologics Main Business
Table 118. Samsung Biologics Latest Developments
Table 119. Mylan Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 120. Mylan Bio Similars & Subsequent Entry Biologic Product Offered
Table 121. Mylan Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 122. Mylan Main Business
Table 123. Mylan Latest Developments
Table 124. Dr. Reddy's Laboratories Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 125. Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Product Offered
Table 126. Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 127. Dr. Reddy's Laboratories Main Business
Table 128. Dr. Reddy's Laboratories Latest Developments
Table 129. Stada Arzneimittel AG Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 130. Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Product Offered
Table 131. Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 132. Stada Arzneimittel AG Main Business
Table 133. Stada Arzneimittel AG Latest Developments
Table 134. AbbVie Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 135. AbbVie Bio Similars & Subsequent Entry Biologic Product Offered
Table 136. AbbVie Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 137. AbbVie Main Business
Table 138. AbbVie Latest Developments
Table 139. Sanofi-Aventis Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 140. Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Product Offered
Table 141. Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 142. Sanofi-Aventis Main Business
Table 143. Sanofi-Aventis Latest Developments
Table 144. Johnson & Johnson Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 145. Johnson & Johnson Bio Similars & Subsequent Entry Biologic Product Offered
Table 146. Johnson & Johnson Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 147. Johnson & Johnson Main Business
Table 148. Johnson & Johnson Latest Developments
Table 149. Novo Nordisk Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 150. Novo Nordisk Bio Similars & Subsequent Entry Biologic Product Offered
Table 151. Novo Nordisk Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 152. Novo Nordisk Main Business
Table 153. Novo Nordisk Latest Developments
Table 154. Eli Lilly Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 155. Eli Lilly Bio Similars & Subsequent Entry Biologic Product Offered
Table 156. Eli Lilly Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 157. Eli Lilly Main Business
Table 158. Eli Lilly Latest Developments
Table 159. Novartis Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 160. Novartis Bio Similars & Subsequent Entry Biologic Product Offered
Table 161. Novartis Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 162. Novartis Main Business
Table 163. Novartis Latest Developments
Table 164. 3sbio Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 165. 3sbio Bio Similars & Subsequent Entry Biologic Product Offered
Table 166. 3sbio Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 167. 3sbio Main Business
Table 168. 3sbio Latest Developments
Table 169. Biotech Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 170. Biotech Bio Similars & Subsequent Entry Biologic Product Offered
Table 171. Biotech Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 172. Biotech Main Business
Table 173. Biotech Latest Developments
Table 174. Gelgen Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 175. Gelgen Bio Similars & Subsequent Entry Biologic Product Offered
Table 176. Gelgen Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 177. Gelgen Main Business
Table 178. Gelgen Latest Developments
Table 179. Innovent Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 180. Innovent Bio Similars & Subsequent Entry Biologic Product Offered
Table 181. Innovent Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 182. Innovent Main Business
Table 183. Innovent Latest Developments
Table 184. Dong Bao Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 185. Dong Bao Bio Similars & Subsequent Entry Biologic Product Offered
Table 186. Dong Bao Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 187. Dong Bao Main Business
Table 188. Dong Bao Latest Developments
Table 189. Ganlee Details, Company Type, Bio Similars & Subsequent Entry Biologic Area Served and Its Competitors
Table 190. Ganlee Bio Similars & Subsequent Entry Biologic Product Offered
Table 191. Ganlee Bio Similars & Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 192. Ganlee Main Business
Table 193. Ganlee Latest Developments
LIST OF FIGURES
Figure 1. Bio Similars & Subsequent Entry Biologic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bio Similars & Subsequent Entry Biologic Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Bio Similars & Subsequent Entry Biologic Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Bio Similars & Subsequent Entry Biologic Sales Market Share by Country/Region (2024)
Figure 8. Bio Similars & Subsequent Entry Biologic Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type in 2024
Figure 10. Bio Similars & Subsequent Entry Biologic in Tumor
Figure 11. Global Bio Similars & Subsequent Entry Biologic Market: Tumor (2020-2025) & ($ millions)
Figure 12. Bio Similars & Subsequent Entry Biologic in Diabetes
Figure 13. Global Bio Similars & Subsequent Entry Biologic Market: Diabetes (2020-2025) & ($ millions)
Figure 14. Bio Similars & Subsequent Entry Biologic in Cardiovascular
Figure 15. Global Bio Similars & Subsequent Entry Biologic Market: Cardiovascular (2020-2025) & ($ millions)
Figure 16. Bio Similars & Subsequent Entry Biologic in Hemophilia
Figure 17. Global Bio Similars & Subsequent Entry Biologic Market: Hemophilia (2020-2025) & ($ millions)
Figure 18. Bio Similars & Subsequent Entry Biologic in Others
Figure 19. Global Bio Similars & Subsequent Entry Biologic Market: Others (2020-2025) & ($ millions)
Figure 20. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application in 2024
Figure 21. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Player in 2024
Figure 22. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Region (2020-2025)
Figure 23. Americas Bio Similars & Subsequent Entry Biologic Market Size 2020-2025 ($ millions)
Figure 24. APAC Bio Similars & Subsequent Entry Biologic Market Size 2020-2025 ($ millions)
Figure 25. Europe Bio Similars & Subsequent Entry Biologic Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size 2020-2025 ($ millions)
Figure 27. Americas Bio Similars & Subsequent Entry Biologic Value Market Share by Country in 2024
Figure 28. United States Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Bio Similars & Subsequent Entry Biologic Market Size Market Share by Region in 2024
Figure 33. APAC Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type (2020-2025)
Figure 34. APAC Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application (2020-2025)
Figure 35. China Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 39. India Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Bio Similars & Subsequent Entry Biologic Market Size Market Share by Country in 2024
Figure 42. Europe Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type (2020-2025)
Figure 43. Europe Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application (2020-2025)
Figure 44. Germany Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 45. France Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 58. APAC Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 59. Europe Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 61. United States Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 62. Canada Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 63. Mexico Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 64. Brazil Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 65. China Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 66. Japan Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 67. Korea Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 69. India Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 70. Australia Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 71. Germany Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 72. France Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 73. UK Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 74. Italy Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 75. Russia Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 76. Egypt Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 77. South Africa Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 78. Israel Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 79. Turkey Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 80. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 1. Bio Similars & Subsequent Entry Biologic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bio Similars & Subsequent Entry Biologic Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Bio Similars & Subsequent Entry Biologic Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Bio Similars & Subsequent Entry Biologic Sales Market Share by Country/Region (2024)
Figure 8. Bio Similars & Subsequent Entry Biologic Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type in 2024
Figure 10. Bio Similars & Subsequent Entry Biologic in Tumor
Figure 11. Global Bio Similars & Subsequent Entry Biologic Market: Tumor (2020-2025) & ($ millions)
Figure 12. Bio Similars & Subsequent Entry Biologic in Diabetes
Figure 13. Global Bio Similars & Subsequent Entry Biologic Market: Diabetes (2020-2025) & ($ millions)
Figure 14. Bio Similars & Subsequent Entry Biologic in Cardiovascular
Figure 15. Global Bio Similars & Subsequent Entry Biologic Market: Cardiovascular (2020-2025) & ($ millions)
Figure 16. Bio Similars & Subsequent Entry Biologic in Hemophilia
Figure 17. Global Bio Similars & Subsequent Entry Biologic Market: Hemophilia (2020-2025) & ($ millions)
Figure 18. Bio Similars & Subsequent Entry Biologic in Others
Figure 19. Global Bio Similars & Subsequent Entry Biologic Market: Others (2020-2025) & ($ millions)
Figure 20. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application in 2024
Figure 21. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Player in 2024
Figure 22. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share by Region (2020-2025)
Figure 23. Americas Bio Similars & Subsequent Entry Biologic Market Size 2020-2025 ($ millions)
Figure 24. APAC Bio Similars & Subsequent Entry Biologic Market Size 2020-2025 ($ millions)
Figure 25. Europe Bio Similars & Subsequent Entry Biologic Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size 2020-2025 ($ millions)
Figure 27. Americas Bio Similars & Subsequent Entry Biologic Value Market Share by Country in 2024
Figure 28. United States Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Bio Similars & Subsequent Entry Biologic Market Size Market Share by Region in 2024
Figure 33. APAC Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type (2020-2025)
Figure 34. APAC Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application (2020-2025)
Figure 35. China Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 39. India Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Bio Similars & Subsequent Entry Biologic Market Size Market Share by Country in 2024
Figure 42. Europe Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type (2020-2025)
Figure 43. Europe Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application (2020-2025)
Figure 44. Germany Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 45. France Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Bio Similars & Subsequent Entry Biologic Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 58. APAC Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 59. Europe Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 61. United States Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 62. Canada Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 63. Mexico Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 64. Brazil Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 65. China Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 66. Japan Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 67. Korea Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 69. India Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 70. Australia Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 71. Germany Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 72. France Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 73. UK Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 74. Italy Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 75. Russia Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 76. Egypt Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 77. South Africa Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 78. Israel Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 79. Turkey Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
Figure 80. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Bio Similars & Subsequent Entry Biologic Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Bio Similars & Subsequent Entry Biologic Market Size 2026-2031 ($ millions)
More Publications
Global Elbow Fixation System Market Growth 2025-2031
US$ 3,660.00
April 2025
105 pages
Global Personal Protective Equipment for Infection Control Market Growth 2023-2029
US$ 3,660.00
February 2023
127 pages
Global Coagulation Electrode Market Growth 2023-2029
US$ 3,660.00
February 2023
108 pages
